Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 686

1.

Phase I study of pazopanib plus TH-302 in advanced solid tumors.

Riedel RF, Meadows KL, Lee PH, Morse MA, Uronis HE, Blobe GC, George DJ, Crawford J, Niedzwiecki D, Rushing CN, Arrowood CC, Hurwitz HI.

Cancer Chemother Pharmacol. 2017 Mar;79(3):611-619. doi: 10.1007/s00280-017-3256-2.

PMID:
28238078
2.

Assessing the interrelatedness of multiple types of adverse childhood experiences and odds for poor health in South Carolina adults.

Crouch E, Strompolis M, Bennett KJ, Morse M, Radcliff E.

Child Abuse Negl. 2017 Mar;65:204-211. doi: 10.1016/j.chiabu.2017.02.007.

PMID:
28189958
3.

Percutaneous biliary drainage catheter insertion in patients with extensive hepatic metastatic tumor burden.

Langman EL, Suhocki PV, Hurwitz HI, Morse MA, Burbridge RA, Smith TP, Kim CY.

J Gastrointest Oncol. 2016 Dec;7(6):875-881. doi: 10.21037/jgo.2016.06.13.

4.

A 64-Year-Old Woman With an Atrophic Plaque on the Thigh-Answer.

Morse MO, Gru AA, Kaffenberger J.

Am J Dermatopathol. 2017 Jan;39(1):62-63. doi: 10.1097/DAD.0000000000000371. No abstract available.

PMID:
28045752
5.

A 64-Year-Old Woman With an Atrophic Plaque on the Thigh-Question.

Morse MO, Gru AA, Kaffenberger J.

Am J Dermatopathol. 2017 Jan;39(1):45-46. doi: 10.1097/DAD.0000000000000372. No abstract available.

PMID:
28045750
6.

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM.

Clark JI, Wong MK, Kaufman HL, Daniels GA, Morse MA, McDermott DF, Agarwala SS, Lewis LD, Stewart JH, Vaishampayan U, Curti B, Gonzalez R, Lutzky J, Rudraptna V, Cranmer LD, Jeter JM, Hauke RJ, Miletello G, Milhem MM, Amin A, Richart JM, Fishman M, Hallmeyer S, Patel SP, Van Veldhuizen P, Agarwal N, Taback B, Treisman JS, Ernstoff MS, Perritt JC, Hua H, Rao TB, Dutcher JP, Aung S.

Clin Genitourin Cancer. 2017 Feb;15(1):31-41.e4. doi: 10.1016/j.clgc.2016.10.008.

7.

Health Information and Global Health Inequity: Point-of-Care Knowledge Systems as a Foundation for Progress.

Hudspeth J, Morse M.

J Gen Intern Med. 2016 Oct 31. [Epub ahead of print]

PMID:
27798781
8.

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.

Sharma P, Callahan MK, Bono P, Kim J, Spiliopoulou P, Calvo E, Pillai RN, Ott PA, de Braud F, Morse M, Le DT, Jaeger D, Chan E, Harbison C, Lin CS, Tschaika M, Azrilevich A, Rosenberg JE.

Lancet Oncol. 2016 Nov;17(11):1590-1598. doi: 10.1016/S1470-2045(16)30496-X.

PMID:
27733243
9.

Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma.

Alva A, Daniels GA, Wong MK, Kaufman HL, Morse MA, McDermott DF, Clark JI, Agarwala SS, Miletello G, Logan TF, Hauke RJ, Curti B, Kirkwood JM, Gonzalez R, Amin A, Fishman M, Agarwal N, Lowder JN, Hua H, Aung S, Dutcher JP.

Cancer Immunol Immunother. 2016 Dec;65(12):1533-1544.

10.

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma.

Buchbinder EI, Gunturi A, Perritt J, Dutcher J, Aung S, Kaufman HL, Ernstoff MS, Miletello GP, Curti BD, Daniels GA, Patel SP, Kirkwood JM, Hallmeyer S, Clark JI, Gonzalez R, Richart JM, Lutzky J, Morse MA, Sullivan RJ, McDermott DF.

J Immunother Cancer. 2016 Sep 20;4:52. doi: 10.1186/s40425-016-0155-8.

11.

Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas.

Pishvaian M, Morse MA, McDevitt J, Norton JD, Ren S, Robbie GJ, Ryan PC, Soukharev S, Bao H, Denlinger CS.

Clin Colorectal Cancer. 2016 Dec;15(4):345-351. doi: 10.1016/j.clcc.2016.07.009.

PMID:
27591895
12.

A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer.

Beg MS, Azad NS, Patel SP, Torrealba J, Mavroukakis S, Beatson MA, Wang XP, Arlen PM, Morse MA.

Cancer Chemother Pharmacol. 2016 Sep;78(3):577-84. doi: 10.1007/s00280-016-3108-5.

PMID:
27449137
13.

Medical Education and Global Health Equity.

Drobac P, Morse M.

AMA J Ethics. 2016 Jul 1;18(7):702-9. doi: 10.1001/journalofethics.2016.18.7.medu1-1607.

14.

Predissociation measurements of bond dissociation energies: VC, VN, and VS.

Johnson EL, Davis QC, Morse MD.

J Chem Phys. 2016 Jun 21;144(23):234306. doi: 10.1063/1.4953782.

PMID:
27334161
15.

Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer.

Quiroga D, Lyerly HK, Morse MA.

Curr Treat Options Oncol. 2016 Aug;17(8):41. doi: 10.1007/s11864-016-0414-4. Review.

PMID:
27315067
16.

Comparison of the diameter, cross-sectional area, and position of the left and right internal jugular vein and carotid artery in adults using ultrasound.

Bos MJ, van Loon RF, Heywood L, Morse MP, van Zundert AA.

J Clin Anesth. 2016 Aug;32:65-9. doi: 10.1016/j.jclinane.2015.12.034.

PMID:
27290948
17.

The bond length and bond energy of gaseous CrW.

Matthew DJ, Oh SH, Sevy A, Morse MD.

J Chem Phys. 2016 Jun 7;144(21):214306. doi: 10.1063/1.4952453.

PMID:
27276956
18.

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.

Antonia SJ, López-Martin JA, Bendell J, Ott PA, Taylor M, Eder JP, Jäger D, Pietanza MC, Le DT, de Braud F, Morse MA, Ascierto PA, Horn L, Amin A, Pillai RN, Evans J, Chau I, Bono P, Atmaca A, Sharma P, Harbison CT, Lin CS, Christensen O, Calvo E.

Lancet Oncol. 2016 Jul;17(7):883-95. doi: 10.1016/S1470-2045(16)30098-5.

PMID:
27269741
19.

The Aerotactic Response of Caulobacter crescentus.

Morse M, Colin R, Wilson LG, Tang JX.

Biophys J. 2016 May 10;110(9):2076-84. doi: 10.1016/j.bpj.2016.03.028.

PMID:
27166815
20.

Training Psychiatrists for Global Mental Health: Cultural Psychiatry, Collaborative Inquiry, and Ethics of Alterity.

Griffith JL, Kohrt B, Dyer A, Polatin P, Morse M, Jabr S, Abdeen S, Gaby LM, Jindal A, Khin EK.

Acad Psychiatry. 2016 Aug;40(4):701-6. doi: 10.1007/s40596-016-0541-z. No abstract available.

PMID:
27060095

Supplemental Content

Support Center